These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 20543101

  • 1. An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells.
    Martin JF, Perry JS, Jakhete NR, Wang X, Bielekova B.
    J Immunol; 2010 Jul 15; 185(2):1311-20. PubMed ID: 20543101
    [Abstract] [Full Text] [Related]

  • 2. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
    Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA, McFarland H, Henkart PA, Martin R.
    Proc Natl Acad Sci U S A; 2006 Apr 11; 103(15):5941-6. PubMed ID: 16585503
    [Abstract] [Full Text] [Related]

  • 3. Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis.
    Sheridan JP, Zhang Y, Riester K, Tang MT, Efros L, Shi J, Harris J, Vexler V, Elkins JS.
    Mult Scler; 2011 Dec 11; 17(12):1441-8. PubMed ID: 21807759
    [Abstract] [Full Text] [Related]

  • 4. Population PK-PD analyses of CD25 occupancy, CD56bright NK cell expansion, and regulatory T cell reduction by daclizumab HYP in subjects with multiple sclerosis.
    Diao L, Hang Y, Othman AA, Mehta D, Amaravadi L, Nestorov I, Tran JQ.
    Br J Clin Pharmacol; 2016 Nov 11; 82(5):1333-1342. PubMed ID: 27333593
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis.
    Su N, Shi SX, Zhu X, Borazanci A, Shi FD, Gan Y.
    J Neuroimmunol; 2014 Nov 15; 276(1-2):180-6. PubMed ID: 25218211
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation.
    Hao J, Campagnolo D, Liu R, Piao W, Shi S, Hu B, Xiang R, Zhou Q, Vollmer T, Van Kaer L, La Cava A, Shi FD.
    Ann Neurol; 2011 Apr 15; 69(4):721-34. PubMed ID: 21425186
    [Abstract] [Full Text] [Related]

  • 7. CD56bright NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections.
    Judge CJ, Kostadinova L, Sherman KE, Butt AA, Falck-Ytter Y, Funderburg NT, Landay AL, Lederman MM, Sieg SF, Sandberg JK, Anthony DD.
    J Leukoc Biol; 2017 Jul 15; 102(1):171-184. PubMed ID: 28400540
    [Abstract] [Full Text] [Related]

  • 8. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4+CD25+Foxp3+ regulatory T cells.
    Yan JJ, Lee JG, Jang JY, Koo TY, Ahn C, Yang J.
    Kidney Int; 2017 Mar 15; 91(3):603-615. PubMed ID: 27914701
    [Abstract] [Full Text] [Related]

  • 9. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.
    Ribeiro A, Laranjeira P, Mendes S, Velada I, Leite C, Andrade P, Santos F, Henriques A, Grãos M, Cardoso CM, Martinho A, Pais M, da Silva CL, Cabral J, Trindade H, Paiva A.
    Stem Cell Res Ther; 2013 Oct 15; 4(5):125. PubMed ID: 24406104
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.
    Ranganath T, Simpson LJ, Ferreira AM, Seiler C, Vendrame E, Zhao N, Fontenot JD, Holmes S, Blish CA.
    Front Immunol; 2020 Oct 15; 11():714. PubMed ID: 32391016
    [Abstract] [Full Text] [Related]

  • 11. Low-dose IL-2 induces CD56bright NK regulation of T cells via NKp44 and NKp46.
    McQuaid SL, Loughran ST, Power PA, Maguire P, Szczygiel A, Johnson PA.
    Clin Exp Immunol; 2020 Jun 15; 200(3):228-241. PubMed ID: 31989589
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.
    Nielsen N, Ødum N, Ursø B, Lanier LL, Spee P.
    PLoS One; 2012 Jun 15; 7(2):e31959. PubMed ID: 22384114
    [Abstract] [Full Text] [Related]

  • 13. Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis.
    Li Z, Lim WK, Mahesh SP, Liu B, Nussenblatt RB.
    J Immunol; 2005 May 01; 174(9):5187-91. PubMed ID: 15843513
    [Abstract] [Full Text] [Related]

  • 14. Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis.
    Jiang W, Chai NR, Maric D, Bielekova B.
    J Immunol; 2011 Jul 15; 187(2):781-90. PubMed ID: 21666061
    [Abstract] [Full Text] [Related]

  • 15. [Influence of regulatory T cells on the functioning of natural killer cells during cancer immunotherapy].
    Chikileva IO, Shubina IZh, Kiselevskiĭ MV.
    Vestn Ross Akad Med Nauk; 2012 Jul 15; (4):60-4. PubMed ID: 22834330
    [Abstract] [Full Text] [Related]

  • 16. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
    Ami K, Ohkawa T, Koike Y, Sato K, Habu Y, Iwai T, Seki S, Hiraide H.
    Clin Exp Immunol; 2002 Jun 15; 128(3):453-9. PubMed ID: 12109440
    [Abstract] [Full Text] [Related]

  • 17. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
    Vargas-Inchaustegui DA, Demberg T, Robert-Guroff M.
    Immunology; 2011 Nov 15; 134(3):326-40. PubMed ID: 21978002
    [Abstract] [Full Text] [Related]

  • 18. Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
    Laroni A, Armentani E, Kerlero de Rosbo N, Ivaldi F, Marcenaro E, Sivori S, Gandhi R, Weiner HL, Moretta A, Mancardi GL, Uccelli A.
    J Autoimmun; 2016 Aug 15; 72():8-18. PubMed ID: 27157273
    [Abstract] [Full Text] [Related]

  • 19. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody.
    Vignali D, Gürth CM, Pellegrini S, Sordi V, Sizzano F, Piemonti L, Monti P.
    Transplantation; 2016 Sep 15; 100(9):1853-61. PubMed ID: 27306531
    [Abstract] [Full Text] [Related]

  • 20. Disengaging the IL-2 receptor with daclizumab enhances IL-7-mediated proliferation of CD4(+) and CD8(+) T cells.
    Monti P, Brigatti C, Heninger AK, Scirpoli M, Bonifacio E.
    Am J Transplant; 2009 Dec 15; 9(12):2727-35. PubMed ID: 19788505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.